2023/03/15
Inspiring Target: Integrin α4/β7 (LPAM-1)
To accelerate the research and development of integrin-targeting drugs, ACROBiosystems has a catalog of all 24 known integrin heterodimers, including integrin α4/β7, expressed through our HEK293 platform and verified by SEC-MALS.
Learn more
2023/03/07
CAR-NK Cell Therapies: Not Completely CRS-proof?
With the increase in CAR-NK and the research into other CAR cell therapies, understanding the cytokine signaling pathway is a must: not only for learning the biological effects but also in the clinical space for diagnostics and treatment strategies. Identifying immune-cell specific or a set of cytok
Learn more
2022/11/16
ACROBiosystems Launches a new Logistics Center in Switzerland
ACROBiosystems launches its first European logistics center and warehouse in Basel, Switzerland.
Learn more
2023/04/18 - 2023/04/21
ICPI WEEK 2023
Speaker: ACROBiosystems and others
Time: 2023.4.18(Tue.)—21(Fri.)
Learn more